Cascade of HIV Care in the Netherlands from 2002 to 2013. Esther Engelhard 14th European AIDS Conference October 18, 2013 Disclosed no conflict of interest.

Slides:



Advertisements
Similar presentations
MINNESOTAS HIV TREATMENT CASCADE. Introduction This slide set describes the continuum of HIV care in Minnesota. The slides rely on data from HIV/AIDS.
Advertisements

1 © 2012 Ipsos © 2014 Ipsos. All rights reserved. Contains Ipsos' Confidential and Proprietary information and may not be disclosed or reproduced without.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
Cascade The Continuum of HIV Care Florida, 2012 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2012, as of 06/30/2013.
Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.
Retention across the continuum of care in a cohort of HIV infected children in rural India G. Alvarez-Uria RDT Hospital, Department of Infectious Diseases,
Late HIV Diagnoses, Georgia,
Illustrating the HIV Care Continuum in U.S. Cities
HIV Care Continuum for the United States and Puerto Rico National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Illustrating the HIV Care Continuum in U.S. Cities Chicago, IL.
Illustrating the HIV Care Continuum in U.S. Cities New Orleans, LA.
Illustrating the HIV Care Continuum in U.S. Cities Atlanta, GA.
Illustrating the HIV Care Continuum in U.S. Cities Philadelphia, PA.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University Health Economics and Epidemiology Research Office July.
Engagement in the HIV care cascade among transgender women enrolled in a public HIV clinic in Buenos Aires, Argentina, M.E. Socías 1,2, O. Sued.
HIV Care Continuum New Diagnoses, 2011, Fulton County, Georgia.
HIV Care Continuum, District 10 Northeast (Athens), Georgia, 2012.
Monitoring Indicators of the National HIV/AIDS Strategy Using Data for Public Health Action Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The United Kingdom provides excellent access and quality of.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
Annual Epidemiological Spotlight on HIV in London: 2014 data Field Epidemiology Services PHE Publications gateway number
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
MINNESOTA’S HIV TREATMENT CASCADE April, Introduction.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
HIV Care Continuum New Diagnoses, 2011, Georgia. Persons with HIV Engaged in Selected Stages of the Continuum of Care, United States Percent
Effects on diagnosis of HIV infection using two HIV rapid tests and linkage to ART in health facilities in China Hao Wu Director of infectious disease.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Future challenges for clinical care of an ageing population infected with HIV: a modelling study Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Beyond Counting – Using HIV Surveillance Data to Monitor Linkage to Care Following Release from Corrections Liza Solomon DrPH, MHS 9 th Academic and Health.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Т.Т.Smolskaya October 2006 Expert Group.
State Office of AIDS Update
Illustrating the HIV Care Continuum in U.S. Cities
Acceptability of early HIV treatment among South Africa women N Garrett, E Norman, V Asari, N Naicker, N Majola, K Leask, Q Abdool Karim and SS Abdool.
Entry into care Failure to initiate timely HIV care after diagnosis is common ~75% of newly diagnosed link to care within 6-12 months Delayed entry into.
Illustrating the HIV Care Continuum in U.S. Cities
East Bay HIV Update Conference
HIV testing guidance: know, treat, prevent
HIV Care Continuum in Manhattan
Illustrating the HIV Care Continuum in U.S. Cities
Brightpoint Health eHIVQual 2017 Cascades.
What do the AETCs Do? Infographic
Illustrating the HIV Care Continuum in U.S. Cities
PLWH in the US data aidsetc.org 11/18/201811/18/2018.
معاونت درمان وزارت بهداشت، درمان و آموزش پزشكي
The HIV Epidemic among People who Inject Drugs
HIV Treatment: What Can You Do to Get and Keep Patients in Care?
Future challenges for clinical care of an ageing population infected with HIV: a modelling study  Dr Mikaela Smit, PhD, Kees Brinkman, MD, Suzanne Geerlings,
What do the AETCs Do? Infographic
Illustrating the HIV Care Continuum in U.S. Cities
Needs Assessment Slides for Module 4
HIV Viral Suppression Rate in U. S
Core Medical Services Waiver
On behalf of the H-TEAM initiative
Presentation transcript:

Cascade of HIV Care in the Netherlands from 2002 to Esther Engelhard 14th European AIDS Conference October 18, 2013 Disclosed no conflict of interest.

HIV infected Virally suppressed DiagnosedLinked to care Retained in care On ART 35.3 million 10.6 million 1)Cascade of care in the Netherlands 2)Influence of hospital characteristics on cascade

Background (1) HIV in the Netherlands  17,006 HIV patients in clinical care  1100 new patients in care in 2012

Background (2) HIV care  General health care: health insurance obligatory  26 legally acknowledged HIV treatment centres  Standards determined by field experts  Criteria: Treatment centreHIV treating physicianSpecialised HIV/AIDS nurse ≥ 2 HIV treating physicians ≥ 1 Specialised nurse ≥ 160 patients ≥ 20 new patients per year Multidisciplinary team meetings National surveillance Access scientific literature Infectious disease specialist HIV/AIDS Experience ≥ 80 patients in care ≥ 10 new patients per year Training Registration as specialised HIV/AIDS nurse (or) HIV/AIDS Experience HIV/AIDS Masterclass

Q-HIV study Cascade of care  HIV care engagement in the Netherlands:  Influence hospital characteristics: Centre size: number of patients in care Number of patients per HIV treating physician Treatment centreHIV treating physicianSpecialised HIV/AIDS nurse ≥ 2 HIV treating physicians ≥ 1 Specialised nurse ≥ 160 patients ≥ 20 new patients per year Multidisciplinary team meetings National surveillance Access scientific literature Infectious disease specialist HIV/AIDS Experience ≥ 80 patients in care ≥ 10 new patients per year Training Registration as specialised HIV/AIDS nurse (or) HIV/AIDS Experience HIV/AIDS Masterclass

Methods (1) Study population  HIV-1-infected patients, enrolled in 2002 or later  ≥18 years at time of HIV diagnosis  Alive and residing in the Netherlands Definitions  Linked to care: study population  Retained in care: evidence of being in care after Jan 1, 2012  On ART: started with ART  Virally suppressed: <100 copies/mL

Methods (2) Stratification  Centre size: Small: ≤500 patients in care. Large: >500 patients in care.  Patients per physician: ≤ 80 patients per physician patients per physician >200 patients per physician

Results (1) Overall  Linked to care: 13,166  Retained in care: 93%  Receiving ART: 79%  Virally suppressed:70%

Results (2) Stratified by treatment centre size: No difference

Results (3) Stratified by no. of patients per physician: No difference

Discussion (1)  Previously published data -Retained in Care: 56% - 68% -On cART: 41% - 50% -Virally suppressed: 32% - 38%  Our data:  93%; 79%; 70%: relatively high  Possible explanations:  Accessibility health care access  Legal regulation of care; criteria HIV treatment centres; monitoring X X X Source: Mugavero et al, 2013

Discussion (2) Challenges:  Diagnose HIV-infected population  Linkage to care diagnosed patients 73% HIV Infected

Conclusions  Relatively high percentage of retention, ART use and viral suppression  No difference between small and large centres  (Early) diagnosis and linkage to care remain a challenge

Acknowledgements  Stichting HIV Monitoring  Ard van Sighem  Q-HIV study group: Frank Kroon Colette Smit Pythia Nieuwkerk Marlies Hulscher Peter Reiss Kees Brinkman Suzanne Geerlings  Aids Fonds